COVID-19. ?????? ?????-19 ????? ??? ?? ?????? ??????????
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All covid-19 patients confirmed with PCR test admitted to the ICU are entered the trial
Exclusion criteria
Exclusion criteria: Age less than 18 Women during pregnancy and lactation Consumers of supplements C, E, Omega 3, Antioxidants in the last 3 months Patients with severe renal failure Patients with liver failure last stage (cirrhosis) Patients with uncontrolled hypertension Patients who do not have a functioning gastrointestinal tract and have not been prescribed oral or intravenous nutrition Patients with drug / food allergies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IL6. Timepoint: The first and 28th of the study. Method of measurement: Blood Sample method: ELISA ; sensivity 0.06 pg/ml.;ESR (Erythrocyte sedimentation rate). Timepoint: The first and 28th of the study. Method of measurement: Automated Modified Westergren.;CRP. Timepoint: The first and 28th of the study. Method of measurement: Blood sampling- ELISA.;Nutrition Status. Timepoint: the first and 28th of the study. Method of measurement: Nutric-score Questionnaire.;Fever. Timepoint: Daily. Method of measurement: Digital Thermometer.;O2 SATURATION. Timepoint: Duration the stay in ICU. Method of measurement: Pulse Oxymeter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of Stay in ICU. Timepoint: Since the first day till end of stay in ICU. Method of measurement: OBSERVATION.;Ventilator Free days. Timepoint: During the stay in ICU. Method of measurement: Observation.;Mortality Rate. Timepoint: During the stay in ICU. Method of measurement: Observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Islamic Azad University